Use the Back button in your browser to see the other results of your search or to select another record.
Efficacy and safety of two different flow rates of nasal high-flow therapy in preterm neonates >= 28 weeks of gestation: a randomized controlled trial [with consumer summary] |
Balasubramanian H, Sakharkar S, Majarikar S, Srinivasan L, Kabra NS, Garg B, Ahmed J |
American Journal of Perinatology 2022 Nov;39(15):1693-1701 |
clinical trial |
10/10 [Eligibility criteria: Yes; Random allocation: Yes; Concealed allocation: Yes; Baseline comparability: Yes; Blind subjects: Yes; Blind therapists: Yes; Blind assessors: Yes; Adequate follow-up: Yes; Intention-to-treat analysis: Yes; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
Copyright release for this abstract has not been granted.
|